|
Merck, a leading science and technology company, announced the expansion of its manufacturing facility in Peenya, Bengaluru. The investment has added new production lines for filtration hardware system in 2025, and in 2026 it followed up with setting up the Pellicon 2 Ultrafiltration Cassette.
“These products are essential to producing life-saving medicines and vaccines. By expanding manufacturing in India, the company is strengthening global supply chains while supporting local innovation and skills,” said Tony Qiu, head of APAC operations, life science business, Merck. “
Merck’s Pellicon 2 Ultrafiltration Cassette is a trusted solution for high-quality purification, supporting a wide range of applications in the pharma and life science industries. The Peenya site has been a hub for global filtration hardware production since 2006, and began manufacturing consumable products, including Prefilter cartridge in 2022. This expansion further strengthens India’s position in Merck’s global network while aligning with the Indian government’s “Make in India” initiative.
|